medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2021, Number 3

<< Back Next >>

Arch Med Fam 2021; 23 (3)

Risk Factors and Prognosis in Patients Treated for Suspected Covid-19

Luna-Bernal IJ, Justo-Enríquez LM

Language: Spanish
References: 29
Page: 127-135
PDF size: 356.39 Kb.


ABSTRACT

Objective: to identify and analyze risk factors and prognostic factors in patients with suspected COVID-19 at UMF 1 in Ciudad Obregón from May 1 to June 30, 2020. Methods: analytical, observational, cross-sectional, retrospective and retro-class study of records of patients with suspected COVID-19, the main clinical, sociodemographic and epidemiological characteristics were collected. Descriptive and inferential statistics were used to identify risk factors and prognoses. A value of p ‹0.05 was considered statistically significant. Results: the sample consisted of 123 women and 107 men with a mean age of 40.3 ± 11.8 years. The main reported symptom was headache, followed by myalgias, arthralgias, and fever. Systemic arterial hypertension implied a risk of aggravation, as well as obesity and diabetes mellitus. Complications were admission to the intensive care unit, pneumonia, intubation, and death, which was the most frequent. Conclusions: In the present study, mortality was slightly higher than what is observed in the general Mexican population. The concomitant disease that most influenced the fatal outcome was the hypertension.


REFERENCES

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. abril de 2020;92(4):401-2. 133

  2. Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome-coronavirus-2 (SARS-COV-2; Coronavirus Disease-19). Korean J Pediatr. 2020;63(4):119–24.

  3. Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med. 2020;9(4):1225.

  4. Kramer U, Kipervasser S, Neufeld MY, Fried I, Nagar S, Andelman F. Is there any correlation between severity of epilepsy and cognitive abilities in patients with temporal lobe epilepsy? Eur J Neurol. febrero de 2006;13(2):130–4.

  5. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. mayo de 2020;109(January):102433.

  6. Pennica A, Conforti G, Falangone F, Martocchia A, Tafaro L, Sentimentale A, et al. Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review. SN Compr Clin Med. 2020;2(6):694–9.

  7. Padhi A, Kumar S, Gupta E, Saxena SK. Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection. Coronavirus Dis 2019. 2020;95–107.

  8. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533–4.

  9. Uddin M, Mustafa F, Rizvi TA, Loney T, Al Suwaidi H, Al-Marzouqi AHH, et al. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions. Viruses. el 10 de mayo de 2020;12(5):526.

  10. Bulut C, Kato Y. Epidemiology of COVID-19. Turkish J Med Sci. 2020;50(SI-1):563–70.

  11. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and application. Ann Intern Med. 2020;172(9):577–82.

  12. Jayaweera M, Perera H, Gunawardana B, Manatunge J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ Res. septiembre de 2020;188(January):109819.

  13. Dirección General de Epidemiología. Datos abiertos. Ciudad de México, México; 2020.

  14. Nicola M, O’Neill N, Sohrabi C, Khan M, Agha M, Agha R. Evidence based management guideline for the COVID-19 pandemic - Review article. Int J Surg. mayo de 2020;77(January):206–16.

  15. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngology. 2020;2(0123456789).

  16. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. febrero de 2020;91:264–6.

  17. Macedo-Pérez M, Barragán-Estudillo ZF, Castillo-Montufar E, Choi SJ, Fernández-Rueda P, Donis-Hernández J, et al. Dermatological findings in COVID-19 patients: Mexican experience. Int J Dermatol. 2020;59(7):872–3.

  18. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.

  19. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87(4):281–6.

  20. He F, Deng Y, Li W. Coronavirus disease 2019: What we know? J Med Virol. 2020;92(7):719–25.

  21. Suárez V, Suarez Quezada M, Oros Ruiz S, Ronquillo De Jesús E. Epidemiología de COVID-19 en México: del 27 de febrero al 30 de abril de 2020. Rev Clínica Española. mayo de 2020;

  22. Kammar-García A, Vidal-Mayo J de J, Vera-Zertuche JM, Lazcano- Hernández M, Vera-López O, Segura-Badilla O, et al. Impact of Comorbidities in Mexican SARS-CoV-2-Positive Patients: A Retrospective Analysis in a National Cohort. Rev Investig Clin. 2020;72(3).

  23. Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, et al. Clinical and Epidemiological Characteristics of Patients Diagnosed with COVID-19 in a Tertiary Care Center in Mexico City: A Prospective Cohort Study. Rev Investig Clin. 2020;72(3).

  24. Barba J. México y el reto de las enfermedades crónicas no transmisibles. El laboratorio también juega un papel importante. Rev Latinoam Patol Clínica y Med Lab. 2018;65(1):4–17.

  25. Rozenberg S, Vandromme J, Martin C. Are we equal in adversity? Does Covid-19 affect women and men differently? Maturitas. 2020;138:62–8.

  26. Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: A systematic review and meta-analysis. J Prev Med Hyg. 2020;61(3):E304–12.

  27. Romo DKJ, et al. Manifestaciones clínicas de la COVID-19. Rev Latinoam Infectología Pediátrica. 2020;33(s1):10–32.

  28. Ejaz H, Alsrhani A, Zafar A, Javed H, Junaid K. COVID-19 and comorbidities: Deleterious impact on infected patients. J Infect Public Health. 2020;13(January):1833–9.

  29. Kario K, Morisawa Y, Sukonthasarn A, Turana Y, Chia YC, Park S, et al. COVID-19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network. J Clin Hypertens. 2020;22(7):1109–19.




2020     |     www.medigraphic.com